您的购物车当前为空
Irsenontrine (E2027) is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9), primarily used for researching neurological diseases.
别名 Irsenontrine, E2027
Irsenontrine (E2027) is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9), primarily used for researching neurological diseases.


TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
凭借在化合物合成方面的丰富经验,我们可以根据您的研究需求为该产品提供快速定制合成服务。
| 产品描述 | Irsenontrine (E2027) is a selective and orally active inhibitor of phosphodiesterase 9 (PDE9), primarily used for researching neurological diseases. |
| 体外活性 | Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 ( PDE 9 ) inhibitor[3]. |
| 体内活性 | Irsenontrine (0.3, 3.3 mg/kg; p.o.) exhibits a significant ameliorative effect on the percentage of exploration of the novel object at 3.3 mg/kg in Scopolamine-induced rats[1]. Irsenontrine (1 mg/kg; p.o.) and memantine hydrochloride (1 mg/kg; p.o.) combined treatment group exhibits a significantly higher percentage of exploration of the novel object than memantine hydrochloride (1 mg/kg) alone[1]. |
| 别名 | Irsenontrine, E2027 |
| 分子量 | 390.443 |
| 分子式 | C22H22N4O3 |
| CAS No. | 1429509-82-9 |
| Smiles | [H][C@@]1(CCOC1)n1ncc2c1c1ccc(cc1[nH]c2=O)-c1c(C)cnc(OC)c1C |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多